{
  "id": "map_1826",
  "title": "Antimicrobianos\\Ny Resistencia",
  "specialty": "Infectolog铆a",
  "tag": " Gu铆a Cl铆nica",
  "node_count": 187,
  "root": {
    "text": "Antimicrobianos\\Ny Resistencia",
    "children": [
      {
        "text": "## Introducci贸n",
        "children": [
          {
            "text": "- Impacto Hist贸rico ATB: Revoluci贸n medicina (desde 1930s), disminuci贸n mortalidad",
            "children": []
          },
          {
            "text": "- Problema Actual: Aumento uso y \"mal uso\" ATB (automedicaci贸n, sobreuso/mal uso con prescripci贸n)",
            "children": []
          },
          {
            "text": "- Preocupaci贸n Principal: Transmisi贸n de Resistencia",
            "children": []
          },
          {
            "text": "- Origen Resistencia: Mecanismos naturales preexistentes (>2 billones a帽os). Uso cl铆nico ATB -> presi贸n selectiva",
            "children": []
          },
          {
            "text": "- Responsabilidad M茅dica: Uso adecuado ATB (impacto individual y social)",
            "children": []
          }
        ]
      },
      {
        "text": "## Conceptos Generales de\\NAntimicrobianos (PK/PD)",
        "children": [
          {
            "text": "- Farmacocin茅tica (PK): Procesos ADME\\N(Absorci贸n, Distribuci贸n, Metabolismo, Excreci贸n)",
            "children": [
              {
                "text": "- Administraci贸n: VO, IV, IM. Medici贸n niveles plasm谩ticos (ej: Vanco, Amika)",
                "children": []
              },
              {
                "text": "- Absorci贸n: Movimiento a circulaci贸n. Biodisponibilidad",
                "children": []
              },
              {
                "text": "- Distribuci贸n: Volumen de Distribuci贸n (Vd). Depende lipofilidad, uni贸n prote铆nas",
                "children": []
              },
              {
                "text": "- Metabolismo: Principalmente hep谩tico (Citocromo P450). Factores gen茅ticos/ambientales",
                "children": []
              },
              {
                "text": "- Excreci贸n: Renal o no renal (biliar, intestinal)",
                "children": []
              }
            ]
          },
          {
            "text": "- Farmacodinamia (PD): Respuesta\\Ndroga, mecanismo acci贸n",
            "children": [
              {
                "text": "- Potencia Antimicrobiana: Bacteriost谩tico vs Bactericida. Influencia concentraci贸n sitio acci贸n",
                "children": []
              },
              {
                "text": "- Interacciones Combinadas: Sinergia, Aditividad (Indiferencia), Antagonismo",
                "children": []
              },
              {
                "text": "- ndices PK/PD\\N(Eficacia):",
                "children": [
                  {
                    "text": "- T>CIM: Tiempo sobre CIM. Agentes tiempo-dependientes (ej: Betalact谩micos, Linezolid)",
                    "children": []
                  },
                  {
                    "text": "- Cmax/CIM: Concentraci贸n m谩xima sobre CIM. Agentes concentraci贸n-dependientes (ej: Fluoroquinolonas, Aminogluc贸sidos)",
                    "children": []
                  },
                  {
                    "text": "- ABC/CIM (AUC/MIC): rea bajo curva sobre CIM. Agentes exposici贸n-dependientes (ej: Vancomicina)",
                    "children": []
                  }
                ]
              },
              {
                "text": "- Efecto Postantibi贸tico (EPA): Inhibici贸n crecimiento persiste bajo CIM. Variable (largo FQ/AG, m铆nimo B-lact谩micos). Implica dosificaci贸n",
                "children": []
              },
              {
                "text": "- Infusi贸n Continua: Opci贸n para ATM sin EPA o tiempo-dependientes",
                "children": []
              }
            ]
          },
          {
            "text": "- Optimizaci贸n Dosificaci贸n: Terapias individualizadas basadas en PK/PD",
            "children": []
          }
        ]
      },
      {
        "text": "## Conceptos Generales de Resistencia",
        "children": [
          {
            "text": "- Mecanismos\\NPrincipales (4 tipos):",
            "children": [
              {
                "text": "- 1. Inhibici贸n\\NEnzim谩tica:",
                "children": [
                  {
                    "text": "- Betalactamasas: Inactivan anillo B-lact谩mico.\\NGenes cromos贸micos/transferibles.\\NClasificaci贸n Ambler (A, B, C, D)",
                    "children": [
                      {
                        "text": "- Clase A: Serina. Penicilinasas, BLEE (Betalactamasas Espectro Extendido), Carbapenemasas KPC. (S. aureus, Enterobacterias, PSAE, BGNNF)",
                        "children": []
                      },
                      {
                        "text": "- Clase B: Metalo-beta-lactamasas (MBL - VIM, NDM, IMP). Zinc. (PSAE, Enterobacterias)",
                        "children": []
                      },
                      {
                        "text": "- Clase C: Cefalosporinasas (AmpC). Serina. (Enterobacter, K. aerogenes, Citrobacter, Serratia, Morganella, Providencia, PSAE)",
                        "children": []
                      },
                      {
                        "text": "- Clase D: Oxacilinasas (OXA). Serina. (A. baumannii)",
                        "children": []
                      },
                      {
                        "text": "- Espectro Inhibici贸n (Resumen Tabla): Detalla qu茅 ATB son afectados por cada tipo",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- Enzimas Modificadoras Aminogluc贸sidos (AG)",
                    "children": []
                  },
                  {
                    "text": "- Enzimas Modificadoras Macr贸lidos, Lincosamidas, Tetraciclinas",
                    "children": []
                  }
                ]
              },
              {
                "text": "- 2. Disminuci贸n de la Permeabilidad:",
                "children": [
                  {
                    "text": "- Rol Porinas (BGN): Mutaciones -> p茅rdida -> resistencia B-lact谩micos, AG, Quinolonas",
                    "children": []
                  }
                ]
              },
              {
                "text": "- 3. Aumento de Eflujo:",
                "children": [
                  {
                    "text": "- Bombas de Eflujo: Expulsi贸n activa ATB (espec铆ficas o multi-droga). Resistencia B-lact谩micos, Quinolonas, Tetraciclinas (BGN); Macr贸lidos, Quinolonas (CGP)",
                    "children": []
                  }
                ]
              },
              {
                "text": "- 4. Alteraci贸n del\\NSitio de Acci贸n:",
                "children": [
                  {
                    "text": "- Alteraci贸n Uni贸n Ribosomal: R a Macr贸lidos/Lincosamidas (Gram+/anaerobios), Linezolid (CGP), AG (Enterob/BGNNF)",
                    "children": []
                  },
                  {
                    "text": "- Alteraci贸n Precursores Pared Celular: R Vancomicina en Enterococcus (E. faecium - genes vanA/vanB)",
                    "children": []
                  },
                  {
                    "text": "- Alteraci贸n\\NEnzimas Diana:",
                    "children": [
                      {
                        "text": "- PBPs (Betalact谩micos): S. pneumoniae R Penicilina, S. aureus R Meticilina (SAMR/MRSA - gen mecA -> PBP2a)",
                        "children": []
                      },
                      {
                        "text": "- ADN girasa/Topoisomerasa IV (Quinolonas): Enterobacterias, PSAE",
                        "children": []
                      },
                      {
                        "text": "- Enzimas v铆a 谩cido f贸lico (Sulfas/Trimetoprim): Staph, BGN",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "## Antimicrobianos\\Npor Familias",
        "children": [
          {
            "text": "- Betalact谩micos y\\NAsociaciones con Inhibidores",
            "children": [
              {
                "text": "- Mecanismo Acci贸n Com煤n: Inhiben s铆ntesis pared (uni贸n PBPs)",
                "children": []
              },
              {
                "text": "- Familias:",
                "children": [
                  {
                    "text": "- Penicilinas",
                    "children": [
                      {
                        "text": "- Naturales\\N(PNC S贸dica,\\NPNC Benzatina)",
                        "children": [
                          {
                            "text": "- Espectro: CGP (Strep no R, E. faecalis), CGN (Neisseria), BGP, Espiroquetas (T. pallidum, Lepto), Anaerobios",
                            "children": []
                          },
                          {
                            "text": "- PK/PD: Ajuste renal. Buena distrib (SNC si inflam)",
                            "children": []
                          },
                          {
                            "text": "- Usos: Infec. Strepto, S铆filis",
                            "children": []
                          },
                          {
                            "text": "- EA: Hipersensibilidad, Jarisch-Herxheimer",
                            "children": []
                          },
                          {
                            "text": "- Resistencia: S. pneumoniae (Chile: R PNC meningitis alta; no meningitis muy baja)",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "- Resistentes a Penicilinasas\\N(Cloxacilina)",
                        "children": [
                          {
                            "text": "- Espectro: CGP (Staphylococcus sensible a meticilina - SAMS, Streptococcus)",
                            "children": []
                          },
                          {
                            "text": "- PK/PD: NO ajuste renal. Buena distrib (incl SNC)",
                            "children": []
                          },
                          {
                            "text": "- Usos: Infecciones SAMS (elecci贸n SNC)",
                            "children": []
                          },
                          {
                            "text": "- Resistencia: SAMR (MRSA). Diferencias SAMR-AH vs SAMR-AC (resistencia, PVL, SCCmec). Vigilancia SAMR-AC Chile",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "- Aminopenicilinas (Ampi, Amoxi) +/-\\NInhibidor (Sulbactam, Clavul谩nico)",
                        "children": [
                          {
                            "text": "- Espectro Base: CGP (Strep, E. faecalis), CGN (Neisseria), BGP (Listeria), BGN (E. coli, Salmonella, Shigella, H. pylori)",
                            "children": []
                          },
                          {
                            "text": "- Espectro + Inhibidor: Agrega S. aureus S, M. catarrhalis, H. influenzae, Enterob (B-lactamasa simple),\\NAnaerobios. Sulbactam activo vs Acinetobacter",
                            "children": []
                          },
                          {
                            "text": "- PK/PD: Ajuste renal. Buena distrib (incl SNC)",
                            "children": []
                          },
                          {
                            "text": "- Usos Base: Infec Strep, E. faecalis (elecci贸n), Listeria (elecci贸n)",
                            "children": []
                          },
                          {
                            "text": "- Usos + Inhibidor: Infec resp, Piel/PB, Intraabdominal, Mordeduras. Acinetobacter (Ampi/Sulba si S)",
                            "children": []
                          },
                          {
                            "text": "- EA: Hipersensibilidad, GI con inhibidor",
                            "children": []
                          },
                          {
                            "text": "- Resistencia: E. faecium R Ampi (alta). H. influenzae R Ampi/Amoxi (alta). Enterobacterias R creciente",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "- Cefalosporinas",
                    "children": [
                      {
                        "text": "- 1陋 Gen (Cefazolina, Cefadroxilo): CGP, algunos BGN (E. coli, Klebsiella, Proteus mirabilis).\\NUso: SAMS (no SNC), Piel/PB, Osteo, Profilaxis Qx, ITU. Pobre SNC. Ajuste renal",
                        "children": []
                      },
                      {
                        "text": "- 2陋 Gen (Cefuroximo): Similar 1G + H. influenzae, M. catarrhalis.\\NUso: Piel/PB, Osteo, ITU, Resp. Ajuste renal",
                        "children": []
                      },
                      {
                        "text": "- 3陋 Gen (Ceftriaxona, Cefotaxima, Ceftazidima): Amplio espectro CGP, CGN, BGN. Ceftazidima anti-Pseudomonas. Ceftriaxona vs Espiroquetas.\\NUso amplio, incl SNC. Ceftriaxona no ajuste renal",
                        "children": []
                      },
                      {
                        "text": "- 4陋 Gen (Cefepime): Amplio espectro, similar 3G + mayor estabilidad vs AmpC. Anti-Pseudomonas, Acinetobacter.\\NUso amplio, incl SNC, Neutropenia febril. Ajuste renal",
                        "children": []
                      },
                      {
                        "text": "- 5陋 Gen (Ceftarolina): Similar Ceftriaxona + SAMR.\\NUso: Piel/PB, NAC, infec SAMR. Pobre SNC. Ajuste renal",
                        "children": []
                      },
                      {
                        "text": "- Asociaciones (Ceftazidima/Avibactam): Cubre BLEE, KPC, AmpC.\\NUso ITU, Intraabd, Infec KPC. NO cubre MBL. Ajuste renal",
                        "children": []
                      },
                      {
                        "text": "- EA: Raros. Hipersensibilidad, Pseudocolelitiasis (Ceftriaxona)",
                        "children": []
                      },
                      {
                        "text": "- Resistencia: S. pneumoniae S Cefotaxima Chile (alta). N. gonorrhoeae S Ceftriaxona Chile (100%).\\NEnterobacterias (BLEE R Cef 3G; AmpC evitar Cef 3G)",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- Ureidopenicilinas\\N(Piperacilina/Tazobactam)",
                    "children": [
                      {
                        "text": "- Espectro: Amplio (CGP, BGN incl PSAE, ACBA, Burkholderia, Anaerobios)",
                        "children": []
                      },
                      {
                        "text": "- PK/PD: Ajuste renal. Pobre SNC",
                        "children": []
                      },
                      {
                        "text": "- Usos: Infecciones graves amplio espectro (Neumon铆a HAP/NAVM, Intraabd, Neutropenia febril)",
                        "children": []
                      },
                      {
                        "text": "- EA: Hipersensibilidad, C. difficile",
                        "children": []
                      },
                      {
                        "text": "- Resistencia: BLEE (S variable, CBP elecci贸n)",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- Carbapen茅micos\\N(Ertapenem, Meropenem, Imipenem)",
                    "children": [
                      {
                        "text": "- Espectro: Muy amplio (CGP, BGN incl BLEE, Anaerobios). Mero/Imi vs PSAE/ACBA. Erta NO vs PSAE/ACBA/Enterococcus",
                        "children": []
                      },
                      {
                        "text": "- PK/PD: Ajuste renal. Mero/Imi penetran SNC",
                        "children": []
                      },
                      {
                        "text": "- Usos: Infecciones graves polimicrobianas/MDR (BLEE elecci贸n). Mero en SNC hospitalaria",
                        "children": []
                      },
                      {
                        "text": "- EA: Hipersensibilidad, C. difficile, Convulsiones (Imi>Erta)",
                        "children": []
                      },
                      {
                        "text": "- Resistencia: Creciente (Carbapenemasas KPC, MBL, OXA; porinas, eflujo). Stenotrophomonas/Burkholderia intr铆nsecamente R",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- Monobact谩micos\\N(Aztreonam)",
                    "children": [
                      {
                        "text": "- Espectro: SOLO BGN aerobios (Enterob, PSAE, ACBA)",
                        "children": []
                      },
                      {
                        "text": "- PK/PD: Ajuste renal. Buena distrib (incl SNC)",
                        "children": []
                      },
                      {
                        "text": "- Usos: Infec BGN. Te贸rico vs MBL (pero limitado por co-resistencias)",
                        "children": []
                      },
                      {
                        "text": "- EA: Hipersensibilidad (reacci贸n cruzada rara)",
                        "children": []
                      },
                      {
                        "text": "- Resistencia: Hidrolizado por BLEE, KPC, AmpC. Estable vs MBL",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "- Glicop茅ptidos\\N(Vancomicina)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Inhibe s铆ntesis pared (une D-ala-D-ala)",
                "children": []
              },
              {
                "text": "- Espectro: CGP (Staph incl SAMR, Strep, Enterococcus), BGP, C. difficile (VO)",
                "children": []
              },
              {
                "text": "- PK/PD: VO no absorbida. Ajuste renal. Monitorizaci贸n niveles (AUC/CIM 400-600)",
                "children": []
              },
              {
                "text": "- Usos: Elecci贸n SAMR, Alergia B-lact谩micos, C. difficile VO",
                "children": []
              },
              {
                "text": "- EA: Reacci贸n infusi贸n, Nefrotoxicidad, Flebitis",
                "children": []
              },
              {
                "text": "- Resistencia: S. aureus R Vanco (no Chile). E. faecium R Vanco (alta prevalencia)",
                "children": []
              }
            ]
          },
          {
            "text": "- Oxazolidinonas\\N(Linezolid)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Inhibe s铆ntesis proteica (subunidad 30S)",
                "children": []
              },
              {
                "text": "- Espectro: CGP (Staph incl SAMR, Strep, Enterococcus incl ERV), BGP, Nocardia",
                "children": []
              },
              {
                "text": "- PK/PD: 100% VO. NO ajuste renal. Buena distrib (incl SNC)",
                "children": []
              },
              {
                "text": "- Usos: ERV, SAMR (alternativa Vanco)",
                "children": []
              },
              {
                "text": "- EA: Citopenias (>2sem tto), Sd. Serotonin茅rgico (raro)",
                "children": []
              }
            ]
          },
          {
            "text": "- Lipop茅ptidos\\N(Daptomicina)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Depolariza membrana bacteriana",
                "children": []
              },
              {
                "text": "- Espectro: SOLO CGP (Staph incl SAMR, Strep, Enterococcus incl ERV)",
                "children": []
              },
              {
                "text": "- PK/PD: Ajuste renal. Inactivado por surfactante (NO neumon铆a). M铆nima llegada SNC",
                "children": []
              },
              {
                "text": "- Usos: Piel/PB, Bacteriemia/Endocarditis (dosis altas), SAMR, ERV",
                "children": []
              },
              {
                "text": "- EA: Elevaci贸n CK, miopat铆a",
                "children": []
              }
            ]
          },
          {
            "text": "- Sulfamidas\\N(Cotrimoxazol - SMX/TMP)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Inhibe v铆a 谩cido f贸lico (secuencial)",
                "children": []
              },
              {
                "text": "- Espectro: CGP (S. aureus incl SAMR, S. pneumo), CGN, BGP, BGN (Enterob, Stenotrophomonas, Burkholderia), Nocardia, P. jirovecii, Toxoplasma",
                "children": []
              },
              {
                "text": "- PK/PD: Buena VO. Ajuste renal. Buena distrib (incl SNC)",
                "children": []
              },
              {
                "text": "- Usos: ITU, Piel/PB, Tto VO SAMR, Elecci贸n Stenotrophomonas/Burkholderia, Oportunistas (PJP, Toxo)",
                "children": []
              },
              {
                "text": "- EA: GI, Hipersensibilidad, Nefrotoxicidad, Hiperkalemia, Citopenias",
                "children": []
              },
              {
                "text": "- Resistencia: S. pneumoniae Chile (~20%)",
                "children": []
              }
            ]
          },
          {
            "text": "- Macr贸lidos \\N(Azitromicina, Claritromicina)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Inhibe s铆ntesis proteica (subunidad 50S)",
                "children": []
              },
              {
                "text": "- Espectro: CGP (Strep), CGN, BGN (H. influ), At铆picos (Mycoplasma, Chlamydia), H. pylori (Claritro)",
                "children": []
              },
              {
                "text": "- PK/PD: Azitro no ajuste renal, Claritro s铆. Pobre SNC",
                "children": []
              },
              {
                "text": "- Usos: Resp altas/bajas (NAC at铆pica), ITS (Chlamydia)",
                "children": []
              },
              {
                "text": "- EA: GI",
                "children": []
              },
              {
                "text": "- Resistencia: S. pneumoniae Chile (~34%). H. pylori R Claritro creciente",
                "children": []
              }
            ]
          },
          {
            "text": "- Lincosamidas\\N(Clindamicina)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Inhibe s铆ntesis proteica (subunidad 50S)",
                "children": []
              },
              {
                "text": "- Espectro: CGP (Staph incl SAMR-AC, Strep), Anaerobios",
                "children": []
              },
              {
                "text": "- PK/PD: VO mala tolerancia. NO ajuste renal. Pobre SNC",
                "children": []
              },
              {
                "text": "- Usos: Shock t贸xico, Infec piel/PB, Empiema, Infec anaer贸bicas (supra-diafragm谩ticas)",
                "children": []
              },
              {
                "text": "- EA: Diarrea, Colitis por C. difficile (alto riesgo)",
                "children": []
              },
              {
                "text": "- Resistencia: S. aureus (variable). S. pneumoniae Chile (~15%). Bacteroides R alta (no intraabd)",
                "children": []
              }
            ]
          },
          {
            "text": "- Tetraciclinas\\N(Doxiciclina)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Inhibe s铆ntesis proteica (subunidad 30S)",
                "children": []
              },
              {
                "text": "- Espectro: Amplio (CGP incl SAMR, BGN, Espiroquetas, At铆picos, Rickettsia, Brucella)",
                "children": []
              },
              {
                "text": "- PK/PD: Buena VO. NO ajuste renal. Moderada SNC",
                "children": []
              },
              {
                "text": "- Usos: Resp, Piel/PB (SAMR VO), ITS, Zoonosis",
                "children": []
              },
              {
                "text": "- EA: Bien tolerado. GI, Fotosensibilidad",
                "children": []
              }
            ]
          },
          {
            "text": "- Glicilciclinas\\N(Tigeciclina)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Inhibe s铆ntesis proteica (subunidad 30S)",
                "children": []
              },
              {
                "text": "- Espectro: Amplio (CGP, BGN incl BLEE, ACBA, Anaerobios). NO vs PSAE",
                "children": []
              },
              {
                "text": "- PK/PD: NO ajuste renal. Pobre nivel s茅rico/SNC",
                "children": []
              },
              {
                "text": "- Usos: Piel/PB, Intraabdominales, Resp",
                "children": []
              },
              {
                "text": "- EA: N谩useas/V贸mitos frecuentes",
                "children": []
              }
            ]
          },
          {
            "text": "- Fluoroquinolonas \\N(Ciprofloxacino, Levofloxacino, Moxifloxacino)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Inhiben ADN girasa/topoisomerasa IV",
                "children": []
              },
              {
                "text": "- Espectro: Amplio (CGP - Levo/Moxi > Cipro; BGN incl PSAE - Cipro/Levo; At铆picos)",
                "children": []
              },
              {
                "text": "- PK/PD: Buena VO. Cipro/Levo ajuste renal, Moxi no. Variable SNC",
                "children": []
              },
              {
                "text": "- Usos: Amplio espectro. Opci贸n VO para PSAE (Cipro/Levo)",
                "children": []
              },
              {
                "text": "- EA: GI, C. difficile, QT prolongado, SNC, Tendinitis/Ruptura tend贸n, Disecci贸n a贸rtica, Neuropat铆a perif茅rica",
                "children": []
              },
              {
                "text": "- Resistencia: S. pneumoniae S Levo Chile (>99%). N. gonorrhoeae R Cipro Chile (alta). Enterobacterias/PSAE R creciente",
                "children": []
              }
            ]
          },
          {
            "text": "- Aminogluc贸sidos\\N(Amikacina, Gentamicina)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Inhibe s铆ntesis proteica (subunidad 30S). Concentraci贸n-dependiente",
                "children": []
              },
              {
                "text": "- Espectro: BGN aerobios (Enterob, PSAE, ACBA)",
                "children": []
              },
              {
                "text": "- PK/PD: EPA largo. Dosis 煤nica diaria. Monitorizaci贸n niveles (valle/peak). Ajuste renal. Pobre distrib SNC/pulm贸n/abscesos",
                "children": []
              },
              {
                "text": "- Usos: Generalmente en combinaci贸n. ITU monoterapia. Infec BGN MDR. Neutropenia febril",
                "children": []
              },
              {
                "text": "- EA: Nefrotoxicidad, Ototoxicidad",
                "children": []
              }
            ]
          },
          {
            "text": "- Polimixinas\\N(Colistina)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Detergente cati贸nico -> da帽a membrana",
                "children": []
              },
              {
                "text": "- Espectro: BGN (Enterob, PSAE, ACBA). R intr铆nseca (Proteus, Serratia, etc)",
                "children": []
              },
              {
                "text": "- PK/PD: Ajuste renal. Pobre distrib SNC/pleura/sinovial",
                "children": []
              },
              {
                "text": "- Usos: ltimo recurso infecciones BGN MDR",
                "children": []
              },
              {
                "text": "- EA: Nefrotoxicidad",
                "children": []
              }
            ]
          },
          {
            "text": "- Nitroimidazoles\\N(Metronidazol)",
            "children": [
              {
                "text": "- Mecanismo Acci贸n: Inhibe s铆ntesis ADN (requiere reducci贸n)",
                "children": []
              },
              {
                "text": "- Espectro: Anaerobios estrictos, H. pylori, Protozoos",
                "children": []
              },
              {
                "text": "- PK/PD: Excelente VO. NO ajuste renal. Buena distrib (incl SNC)",
                "children": []
              },
              {
                "text": "- Usos: Elecci贸n infecciones anaer贸bicas, C. difficile",
                "children": []
              },
              {
                "text": "- EA: GI, Neuropat铆a perif茅rica (uso prolongado)",
                "children": []
              }
            ]
          },
          {
            "text": "- Agentes\\NV铆a Urinaria",
            "children": [
              {
                "text": "- Nitrofuranto铆na",
                "children": [
                  {
                    "text": "- Mecanismo Acci贸n: Da帽o macromol茅culas (prote铆nas ribosomales, ADN, ARN)",
                    "children": []
                  },
                  {
                    "text": "- Espectro: Enterococcus, Enterobacterias",
                    "children": []
                  },
                  {
                    "text": "- PK/PD: Buena VO. Evitar ClCr <30. Concentraci贸n solo urinaria",
                    "children": []
                  },
                  {
                    "text": "- Usos: SOLO ITU baja (Cistitis)",
                    "children": []
                  },
                  {
                    "text": "- EA: GI, Toxicidad pulmonar (rara)",
                    "children": []
                  }
                ]
              },
              {
                "text": "- Fosfomicina\\N(Trometamol VO)",
                "children": [
                  {
                    "text": "- Mecanismo Acci贸n: Inhibe s铆ntesis pared",
                    "children": []
                  },
                  {
                    "text": "- Espectro: Amplio (CGP incl ERV, BGN incl BLEE/KPC/PSAE)",
                    "children": []
                  },
                  {
                    "text": "- PK/PD: Baja absorci贸n VO. Concentraci贸n urinaria/prost谩tica",
                    "children": []
                  },
                  {
                    "text": "- Usos: ITU baja (dosis 煤nica)",
                    "children": []
                  },
                  {
                    "text": "- EA: GI",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1701",
      "title": "SAVE Score (2015)\\NSurvival After Veno-arterial ECMO\\N\\nScore pronostico para sobrevida\\nen VA-ECMO por shock cardiogenico\\nPredice mortalidad hospitalaria"
    },
    {
      "id": "map_1380",
      "title": "SEPSIS Y SHOCK SPTICO  Dic 2024"
    }
  ],
  "source_file": "05.06. Antimicrobianos y Resistencia-2025.smmx",
  "created": "2026-02-07T15:42:58.901787"
}